Reference
Balducci C, et al. Guillain-Barre syndrome after treatment with alemtuzumab in a patient with multiple sclerosis. Multiple Sclerosis Journal 24 (Suppl.): 929-930 abstr. EP1644, No. 2, Oct 2018. Available from: URL: http://doi.org/10.1177/1352458518798592 [abstract] - Italy
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1776, 28 (2019). https://doi.org/10.1007/s40278-019-70186-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-70186-2